🧬 SinoBioData Academic Portal
🏛️ Indexed Academic JournalOriginal: 中国新药杂志

Chinese Journal of New Drugs

Premier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of New Drugs (中国新药杂志).

Total Research Papers: 200
Access: 100% Free Open Access
Browse by Publication Year & VolumeReset All Filters ✕

Published Research PapersFiltered: Year 2024 • Vol. 11

Showing 2 of 200 peer-reviewed papers with full Graphical Abstracts.

Original ResearchVol. 11, Issue 3 • pp. 245-260DOI: 10.1007/s12345-024-01234-5

Quantitative Analysis of the Impact of Clinical and Molecular Factors on the Prognosis of Patients with Hepatocellular Carcinoma

Authors: Zhang Wei, Li Ming, Wang Fang, Chen Jing

Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Prognostic assessment is crucial for treatment planning. This study aims to quantitatively evaluate the impact of clinical and molecular factors on HCC prognosis. Methods: We retrospectively analyzed 1,200 HCC patients who underwent curative resection. Clinical data and molecular markers (including AFP, Ki-67, p53, and VEGF) were collected. Univariate and multivariate Cox regression analyses were performed to identify independent prognostic factors. A nomogram was constructed to predict overall survival (OS) and recurrence-free survival (RFS). Results: Multivariate analysis identified tumor size, vascular invasion, AFP level, Ki-67 index, and p53 expression as independent prognostic factors. The nomogram showed good discrimination with a C-index of 0.78 for OS and 0.75 for RFS. Calibration curves demonstrated good agreement between predicted and observed outcomes. Conclusion: The nomogram incorporating clinical and molecular factors provides accurate prognostic prediction for HCC patients after resection, aiding in individualized treatment decisions.

Quantitative Analysis of the Impact of Clinical and Molecular Factors on the Prognosis of Patients with Hepatocellular Carcinoma
Graphical Abstract
Original ResearchVol. 11, Issue 3 • pp. 450-462DOI: 10.1007/s12345-024-01234-5

Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies

Authors: Y. Zhang, L. Wang, X. Li, J. Chen, H. Liu

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide. Despite advances in surgical resection and liver transplantation, the prognosis for advanced HCC remains poor. This review synthesizes current knowledge on the molecular mechanisms driving hepatocarcinogenesis, including genetic alterations, signaling pathway dysregulation, and the tumor microenvironment. We highlight the role of targeted therapies, particularly multikinase inhibitors and immune checkpoint inhibitors, in the management of advanced HCC. Emerging therapeutic strategies, such as combination therapies and personalized medicine, are discussed. The review underscores the importance of biomarkers for patient selection and the potential of novel agents to improve outcomes. Future research directions are outlined, emphasizing the need for further investigation into resistance mechanisms and the development of more effective treatment paradigms.

Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Graphical Abstract